BioNTech

NEWS

Policy

Biopharma Update on the Novel Coronavirus: July 20

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 20, 2020.

July 20, 2020

2 min read

BioSpace Editorial Staff

Policy

Biopharma Update on the Novel Coronavirus: July 17

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 17, 2020.

July 16, 2020

5 min read

BioSpace Editorial Staff

Drug Development

Biopharma Update on the Novel Coronavirus: July 13

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 13, 2020.

July 13, 2020

3 min read

BioSpace Editorial Staff

Policy

BioNTech, Pfizer Snag Fast Track Designation for Two COVID-19 Vaccine Candidates

The designation will provide for an expedited pathway for regulatory review of the preventative medication, which could come later this year.

July 13, 2020

2 min read

Alex Keown

Business

BioNTech CEO Believes COVID-19 Vaccine Could be Ready for Approval by December

BioNTech Chief Executive Officer Ugur Sahin predicts the company’s vaccine for COVID-19, which is it co-developing with Pfizer, could be ready for regulatory approval by the end of the year, with hundreds of millions of doses available for immediate distribution.

July 10, 2020

3 min read

Alex Keown

Policy

Biopharma Update on the Novel Coronavirus: July 10

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 10, 2020.

July 9, 2020

4 min read

BioSpace Editorial Staff

Drug Development

Clinical Catch-Up: June 29-July 3

Heading into the 4th of July holiday in the U.S., there was still a fair amount of clinical trial news last week. Here’s a look.

July 2, 2020

7 min read

Mark Terry

Drug Development

Pfizer and BioNTech’s COVID-19 Vaccine Shows Early Positive Data

Pfizer and BioNTech indicate that this data, along with preclinical data and additional data being generated, will be leveraged to choose a dose level and pick the best vaccine candidate out of the several being evaluated.

July 1, 2020

4 min read

Mark Terry